Camille Shore

Sr. Director, Regulatory Affairs at Versartis Inc - Menlo Park, California, United States

Camille Shore's Colleagues at Versartis Inc
Camille Shore's Contact Details
HQ
Location
Pacifica,California,United States
Company
Versartis Inc
Camille Shore's Company Details

Versartis Inc

Menlo Park, California, United States • 1 Employees
Pharmaceuticals

Versartis, Inc. is an endocrine-focused biopharmaceutical company. The Company is engaged in developing a long-acting form of recombinant human growth hormone, somavaratan (VRS-317), for growth hormone deficiency (GHD), an orphan disease. The Company's first indication for somavaratan is pediatric GHD. The Company may develop somavaratan for additional growth disorders, such as idiopathic short stature (ISS), small for gestational age (SGA) and Turner Syndrome. Somavaratan is engineered using XTEN technology to extend the residence time in the bloodstream by reducing the clearance of recombinant human growth hormone (rhGH) from the body by the two primary mechanisms, kidney filtration and receptor mediated clearance.

Details about Versartis Inc
Frequently Asked Questions about Camille Shore
Camille Shore currently works for Versartis Inc.
Camille Shore's role at Versartis Inc is Sr. Director, Regulatory Affairs.
Camille Shore's email address is ***@aravive.com. To view Camille Shore's full email address, please signup to ConnectPlex.
Camille Shore works in the Pharmaceuticals industry.
Camille Shore's colleagues at Versartis Inc are John Kotek and others.
Camille Shore's phone number is
See more information about Camille Shore